References
- AhujaMDhakeASSharmaSKMajumdarDKTopical ocular delivery of NSAIDsAAPS J20081022924118437583
- ColinJThe role of NSAIDs in the management of postoperative ophthalmic inflammationDrugs2007671291130817547472
- SchalnusRTopical nonsteroidal anti-inflammatory therapy in ophthalmologyOphthalmologica2003217899812592044
- AbelRAbelADPerioperative antibiotic, steroidal, and nonsteroidal anti-inflammatory agents in cataract intraocular lens surgeryCurr Opin Ophthalmol199673942
- PolanskyJWeinrebRSteroids as anti-inflammatory agentSearsMPharmacology of the EyeHeidelbergSpringer1984460583
- RaizmanMCorticosteroid therapy of eye diseases: fifty years laterArch Ophthalmol1996114100010018694704
- JonesBMNevilleMWNepafenac: an ophthalmic nonsteroidal anti-inflammatory drug for pain after cataract surgeryAnn Pharmacother20134789289623715071
- KimSJSchoenbergerSDThorneJEEhlersJPYehSBakriSJTopical nonsteroidal anti-inflammatory drugs and cataract surgery: a report by the American Academy of OphthalmologyOphthalmology20151222159216826123091
- BromSite [prescribing information]2016 Available from: https://www.bromsite.com/pdf/BromSitePI.pdfAccessed April 30, 2018
- SiECBowmanLMHosseiniKPharmacokinetic comparisons of bromfenac in DuraSite and XibromJ Ocul Pharmacol Ther2010276166
- BowmanLMSiEPangJArchibaldRFriedlaenderMDevelopment of a topical polymeric mucoadhesive ocular delivery system for azithromycinJ Ocul Pharmacol Ther20092513313919284320
- SheppardJDCockrumPCJusticeAJasekMCIn vivo pharmacokinetics of bromfenac ophthalmic solution 0.075%, bromfenac ophthalmic solution 0.07%, and nepafenac/amfenac ophthalmic suspension 0.3% in rabbitsOphthalmol TherIn press2018
- DuboisRNAbramsonSBCroffordLCyclooxygenase in biology and diseaseFASEB J199812106310739737710
- OkaTShearerTRAzumaMInvolvement of cyclooxygenase-2 in rat models of conjunctivitisCurr Eye Res200429273415370364
- Guex-CrosierYNon-steroidal anti-inflammatory drugs and ocular inflammationKlin Monbl Augenheilkd2001218305308 French11417322
- BonazziAMastyuginVMieyalPARegulation of cyclooxygenase-2 by hypoxia and peroxisome proliferators in the corneal epitheliumJ Biol Chem20002752837284410644750
- MasferrerJLKulkarniPSCyclooxygenase-2 inhibitors: a new approach to the therapy of ocular inflammationSurv Ophthalmol199741S35S409154274
- WaltersTRaizmanMErnestEGaytonJLehmanJIn vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenacJ Cataract Refract Surg2007331539154517720067
- KidaTKozaiSTakahashiHIsakaMTokushigeHSakamotoTPharmacokinetics and efficacy of topically applied nonsteroidal anti-inflammatory drugs in retinochoroidal tissues in rabbitsPLoS One20149e9648124796327
- ShafieeABowmanLMHouEHosseiniKAqueous humor penetration of ketorolac formulated in DuraSite or DuraSite 2 delivery systems compared to Acular LS in rabbitsJ Ocul Pharmacol Ther20132981281623992042